Groups
Company Size (Fulltime employees)
Looking for
Functionality
Headquartner in China
Biotech/Pharma Category
Biotech/Pharma Asset Stage
Medtech Category
Medtech Development Stage
Index
Countries
Reset

Tractivus SL Spain

TRACTIVUS is a company derived from the research group GEMAT (IQS-Ramón Llull University) and IDIBELL (Bellvitge Biomedical Research Institute), located in Barcelona. We are an innovative company with expertise in antibacterial coatings, easy to be implemented on a wide range of medical devices.

PHOBOSTech™ technology have been developed over the years in Tractivus SL as a solution to the current problems of medical devices. Our cost-effective patented technology allows to create nanostructures on the surface, preventing bacteria attachment and, therefore, bacteria colonization. As a result our devices show higher lifetime, lower associated costs, and no post-implantation problems without adverse effect on the patients.

Tractivus SL combines the experience of the research groups and a unique solution designed to root out the colonization of the devices through a micro- and nano-structured coating that protects the device from adhesion and bacterial colonization. The team has worked on all aspects of the development: material selection, regulatory strategy, risk reduction, clinical trials, partners, stakeholders... aiming to maximize the success of both the project and the investors.
Website:
https://www.tractivus.com/
Company Size (Fulltime employees)
1-10
Year of foundation
2015
Looking for
Please specify your partnering goal
Establish commercial out-license agreement to bring our product to the market
Headquartner in China
No
Plan in China
We are looking for partners to grow up and achieve the NMPA certificates, clinical studies and markers in Asia. We are interested in manufacture and distributor partners in China for our technology and, also, we are looking for potential license-customers for medical devices modification.
Biotech/Pharma Category
Medtech Category
Medtech Information 1, Device Name|Description|Development Stage|Licensed Countries
PHOBOSTech|Bacteriophobic/Bacteriostatic/Bactericide coating for streacheable silicone-based surfaces|Full developed|-
Medtech Information 2
UroPHOB|Foley urinary catheter with PHOBOSTech tecnology|Scale lab validated/Preclinical test performed/Designing clinical test|-
Medtech Development Stage
Joan Gilabert
Joan Gilabert
CEO 
Functionality
Management

Whale Bay & Co Netherlands

Whale Bay & Co is a boutique financing firm focused solely on the life sciences industry. Based in Rotterdam (the Netherlands) and Basel (Switzerland) we serve SME's, investors and mid-size strategic companies in Biotech, Pharma, MedTech and Digital Health in the strategy and financial space: licensing, financing, M&A, valuation and outsources BD. We have a keen interest to expand our network and business into China. In the context of specific mandates we would like to connect with:

- pharma & medtech companies for outlicensing/JV collaborations with our clients
- investors looking for early and late stage pharma, biotech and medtech investment opportunities
- (FoF)investors interested in investment in funds
Website:
www.whalebayco.com
Company Size (Fulltime employees)
1-10
Year of foundation
2015
Looking for
Funding Status
private
Headquartner in China
No
Plan in China
Expand our network and look for partners /investors for our US and EU clients
Jasper Evers
Founding Partner 
Functionality
Management

WPD Pharmaceuticals Canada

WPD has 8 novel drug candidates with 4 that are in clinical development stage and 4 in pre-clinical development. These drug candidates were researched at institutions including the Mayo Clinic and Emory University, and WPD currently has ongoing collaborations with Wake Forest University and leading hospitals and academic centers in Poland.

Alongside direct investment of $60 million, over $29 million of grant funding (total of $89 million USD) has gone towards the development of our robust drug development pipeline with a focus on melanoma, brain cancer, leukemia, and pancreatic cancer. Notably, these funds do not include $14 million USD in grants recently awarded to WPD Pharmaceuticals from The National Centre for Research and Development in Poland.

With a groundswell of multi-continental grant support and a diverse portfolio of breakthrough drug technologies, WPD Pharmaceuticals is now strategically positioned to enter the market with blockbuster potential.

Website:
https://www.wpdpharmaceuticals.com/about/overview/
Company Size (Fulltime employees)
11-50
Year of foundation
2017
Stock Market and Ticker/Symbol/Number
WCSE: BIO
Looking for
Please specify your partnering goal
We are looking for investors and partners for co-develop our product in China and co-develop partner product in EU.
Now raising (In USD)
between $ 3 million - $10 million
Headquartner in China
No
Plan in China
We are looking for investors and partners for co-develop our product in China and co-develop partner product in EU.
Biotech/Pharma Category
Investment Focus
Seeking funding to move from pre clinical stage to Phase 1/2 clinical trial and support co-development in EU
Mariusz Olejniczak
CEO 
Functionality
Management

www.eudendron.com Italy

Eudendron is an Italian biotech company founded by Dr. Mauro Angiolini and Dr. Fabio Zuccotto. Eudendron develops anti-cancer agents for applications within the precision medicine model, adopting a tumor agnostic approach and targeting populations of patients hosting genetically defined cancers. Purpose of the company is to advance novel cancer treatments from their inception to Phase I/II. The activities of the company are also focused on the identification of novel drugs effective against protein kinase mutations responsible for clinical drug resistance. Eudendron discovered and patented a new class of highly specific inhibitors with excellent anti-cancer properties against several types of cancer cells. Patents in Europe and in USA have already been granted covering inhibitors of relevant oncology targets and their mutations. Lung and thyroid cancer, lymphoma, neuroblastoma and cutaneous cancer are diseases with unmet medical need of particular interest. Especially for neuroblastoma, the company identified drugs with a potent and specific profile. Eudendron is committed to identify Investors and/or industrial Partners to advance the pipeline programs toward the clinical stage. Basket trials will be finally designed following an agnostic clinical development.
Website:
www.eudendron.com
Company Size (Fulltime employees)
1-10
Year of foundation
2012
Looking for
Please specify your partnering goal
Partenership , fundraising, out-licensing
Headquartner in China
No
Biotech/Pharma Category
Mauro Angiolini
CEO 
Functionality
Management

上海徽锐生物科技有限公司 China

we are a company focusing on the research and development of new drug
Website:
www.aitectt.cn
Looking for
Headquartner in China
Yes
Biotech/Pharma Category
Service Description
医疗技术 Medical technologies: use ai to empower drug discovery
shen yuli
GM 

丹麦科技创业中心 China

Partnership between Ministry of Foreign Affair and Ministry of Higher Education and Science of Denmark. Help danish high-tech companies and research instututes to enter Chinese market and find Chinese collaborators
Website:
https://kina.um.dk/en/about-us/danish-representations-in-china/innovation-center-shanghai/
Looking for
Headquartner in China
No
昱 祁
创新合作官员 
Functionality
Management

凯因科技 China

Kawin Technology is a Chinese biopharma engaging in liver disease and virus-related disease. 
The turnover in 2019 is over 800 million RMB (115 millon USD). 
We are now in IPO process and projected to be listed in China this year. 

What we are looking for:
Antivirals and liver disease: early staged in-licensing  
Technical collaboration, out-licensing

Website:
http://www.kawin.com.cn
Looking for
Headquartner in China
Yes
Slides Deck
(jpg, 321.13KB)
Yu Cai
BD Head 
Functionality
Business Development

华大基因 China

生物科技公司
Website:
Www.genomics.cn
Looking for
Headquartner in China
Yes
Biotech/Pharma Category
Service Description
诊断产品 Diagnostic products
刘 冬媛
业务发展副总监 

荷兰王国驻华大使馆 China

荷兰驻华大使馆。
协助荷兰企业对接中国合作伙伴。
Website:
niyuhelan.nl
Looking for
Headquartner in China
No
燕 梁
生命科学和医学官员 
Functionality
Research and Clinical